Inogen (INGN)
(Delayed Data from NSDQ)
$12.51 USD
+0.29 (2.37%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $12.49 -0.02 (-0.16%) 7:58 PM ET
2-Buy of 5 2
B Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$12.51 USD
+0.29 (2.37%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $12.49 -0.02 (-0.16%) 7:58 PM ET
2-Buy of 5 2
B Value A Growth A Momentum A VGM
Zacks News
Hologic Wins FDA Approval for Genius 3D Mammography Exam
by Zacks Equity Research
Hologic, Inc. (HOLX) continues to expand its Breast and Skeletal Health business through innovation and product development.
Zimmer Biomet Rides on Spine Business, Knee Challenges Stay
by Zacks Equity Research
On Jun 6, we issued an updated research report on Warsaw, IN-based Zimmer Biomet Holdings Inc. (ZBH).
Bruker Grows on NMR & Nano Businesses amid Several Odds
by Zacks Equity Research
On Jun 6, we issued an updated research report on Billerica, MA-based Bruker Corporation (BRKR), a manufacturer of proprietary life science and materials research systems.
Boston Scientific Wins CE Mark for Vercise Gevia DBS System (revised)
by Zacks Equity Research
Generally, DBS therapy is a surgical procedure of placing a device that stimulates specific areas in the brain using electrical signals.
Cardiovascular Systems Innovation On Track, Competition Rife
by Zacks Equity Research
On Jun 6, we issued an updated research report on St. Paul, MN-based Cardiovascular Systems, Inc. (CSII).
Here's Why You Should Bet on Humana (HUM) Stock Right Now
by Zacks Equity Research
Louisville-based Humana Inc. (HUM), one of the largest health care plan providers in the United States, has been an investor favorite, given its strong fundamentals
Medtronic SureTune3 Obtains Health Canada License for DBS
by Zacks Equity Research
Medtronic plc (MDT) recently announced the receipt of Health Canada license for SureTune 3 software for deep brain stimulation (DBS).
Boston Scientific Wins CE Mark for Vercise Gevia DBS System
by Zacks Equity Research
Boston Scientific Corporation (BSX) recently won CE mark for its Vercise Gevia Deep Brain Stimulation (DBS) System.
HealthEquity (HQY) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
HealthEquity Inc (HQY) reported earnings of 19 cents per share in the first quarter of fiscal 2018, higher than the Zacks Consensus Estimate of 16 cents.
Amedisys (AMED) Prospects Impressive Amid Tough Competition
by Zacks Equity Research
On Jun 5, we issued an updated research report on leading molecular diagnostic company, Amedisys, Inc. (AMED).
Abiomed (ABMD) at 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Share price of Abiomed, Inc. (ABMD), scaled a new 52-week high of $142.95 on Jun 5, eventually closing a bit lower at $141.81.
Cerner (CERN) to Develop Electronic Health Records System
by Zacks Equity Research
Cerner Corp (CERN) recently announced that it has been chosen by the U.S. Department of Veterans Affairs to develop an electronic health record (EHR) system.
Edwards Lifesciences (EW) SAPIEN 3 THV Gets FDA Approval
by Zacks Equity Research
Edwards Lifesciences Corporation (EW) recently announced the receipt of FDA approval for aortic and mitral valve-in-valve procedures using SAPIEN 3 transcatheter heart valve (THV).
Strength Seen in DexCom (DXCM): Stock Adds 5% in Session
by Zacks Equity Research
DexCom, Inc. (DXCM) shares rose over 5% in the last trading session.
Tenet Healthcare Prices New Notes to Repay Existing Debts
by Zacks Equity Research
Tenet Healthcare Corporation (THC) recently priced the previously announced private offering of newly issued notes.
QIAGEN Strengthens Cancer Research Foothold on New License
by Zacks Equity Research
QIAGEN N.V. (QGEN) has received a worldwide license for biomarkers to be used in identifying patients who may have benefited from immune-oncology (I-O) therapies in cancer treatment.
Myriad Genetics BRACAnalysis CDx in OlympiAD Results Positive
by Zacks Equity Research
Myriad Genetics, Inc. (MYGN), a leading molecular diagnostics and personalized medicine company recently unveiled positive data pertaining to its BRACAnalysis CDx test.
Align Sets Up Manufacturing Center in China, Grows in APAC
by Zacks Equity Research
Align Technology (ALGN) has recently inaugurated a new Invisalign treatment planning facility in Chengdu, China.
Inogen Secures New Direct-to-Consumer Business Facility
by Zacks Equity Research
Inogen, Inc. (INGN) announced that it has secured a new business facility in the Cleveland, OH area.
Abbott Laboratories at 52-Week High on Product Line, Buyouts
by Zacks Equity Research
Share price of IL-based Abbott Laboratories (ABT) scaled a new 52-week high of $46.55 on Jun 2, eventually closing a bit lower at $46.50.
QIAGEN & Bristol-Myers Squibb Partner on Cancer Research
by Zacks Equity Research
QIAGEN N.V. (QGEN) has made significant advancement in the field of cancer research through the use of its revolutionary next-generation sequencing (NGS) technology.
Quintiles IMS Holdings (Q) Holds Secondary Offering (revised)
by Zacks Equity Research
Q held a secondary offering of 10.6m shares, of which they repurchased $300m worth.
Mead Johnson's Shareholders Approve Reckitt Benckiser Deal
by Zacks Equity Research
Mead Johnson's (MJN) stockholders have okayed the impending merger with Reckitt Benckiser Group.
Hill-Rom Holdings Hits 52-Week High on Solid Product Line
by Zacks Equity Research
Share price of Batesville, IN-based Hill-Rom Holdings, Inc. (HRC) scaled a new 52-week high of $78.51 on Jun 1.
The Cooper Companies (COO) Beats Earnings Estimates in Q2
by Zacks Equity Research
The Cooper Companies Inc. (COO) reported adjusted earnings of $2.50 in second-quarter fiscal 2017, surpassing the Zacks Consensus Estimate by 25 cents and improving from $2.05 in the year-ago quarter.